Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
about
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewMycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistanceNew anti-tuberculosis drugs and regimens: 2015 updateIndividualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, IndiaSulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxis.The multidrug-resistant tuberculosis threat: old problems and new solutionsPharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of TuberculosisThe potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.Quantification of co-trimoxazole in serum and plasma using MS/MS.Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosisOld Antibiotics for Tuberculosis.Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis.Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
P2860
Q26764847-ECEB1836-3EC9-4D1B-9A9B-A1B8E8CF1BE6Q28082718-5D176374-D2A8-4962-85EA-5F5E7B404FB5Q28596775-74F686CE-C20D-4DB1-8A6F-07FA03503677Q30275673-D5FC11B6-6707-4BB2-8A02-C3B612348EB1Q35032535-F977411B-9F8E-4310-983C-890038676EECQ35960967-8C3DA123-26AE-4287-B205-B756AC7E7180Q36138237-3CAD5C20-5634-489B-83B5-7748A0B7F362Q37023099-AC49CE94-53E6-4A14-AC2F-0D3CEB555916Q38806183-20F2EAFC-8F33-493F-9224-CF9017577DD7Q38942938-8F9A28EB-8836-4E12-95FD-7DC1E8AB0199Q38954085-9D7D4A0E-2DC1-43FA-B7EA-56D3BE95A34EQ40270392-DB682A1A-9FC8-41F8-B5B1-7C42E9502019Q47689257-1822D2D0-D305-4E7E-86DD-058DC5D4EAFFQ49562382-E1CA1700-0FC6-43CA-AFCA-2F7A7C881199Q50118836-C20C365D-B8D8-4820-BD8A-FD78F0707DF0Q50508187-2F103F65-4DCB-4A31-8AF5-75C83F9A26F3Q50780166-6EFFAAB3-F7CC-43D6-BEB2-4435C1198555
P2860
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@ast
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@en
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@nl
type
label
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@ast
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@en
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@nl
prefLabel
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@ast
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@en
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@nl
P2093
P1476
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
@en
P2093
Arianna D Pranger
Jan-Willem C Alffenaar
Jos G W Kosterink
Noor Alsaad
Richard van Altena
Tjip S van der Werf
Wiel C M de Lange
P304
P356
10.1183/09031936.00114812
P577
2012-10-25T00:00:00Z